Translate this page into:
Dopamine transporter single-photon emission computed tomography brain scan: A reliable way to distinguish between degenerative and drug-induced parkinsonism
Address for correspondence: Dr. Shakya Bhattacharjee, Flat 96, 21, Plymbridge Lane, Plymouth, PL68AX, UK. E-mail: bubai.shakya@gmail.com
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Sir,
A 54-year-old man on valproate because of bipolar affective disorders developed extra-pyramidal symptoms suggestive of drug-induced parkinsonism. His symptoms persisted despite stopping valproate. He had a dopamine transporter (DaT) scan and single-photon emission computed tomography (SPECT) scan. The DaT scan showed abnormality (Grade 1) [Table 1] in the right putaminal tracer uptake suggestive of degenerative parkinsonism instead of drug-induced parkinsonism [Figure 1a and b].[12]
![(a) Normal dopamine transporter single-photon emission computed tomography scan appearance, normal dopamine transporter scan appearance with head of the caudate nucleus appearing like a full stop (large arrow), and the putamen appearing like tail (small arrow). (b) Abnormal dopamine transporter scan in our patient: The left side is normal with normal putaminal tail (large arrow). The right side has abnormal tracer uptake - absence of putaminal tail, but the normal appearance of the caudate nucleus was like a full stop (small open arrow) (Type 1 abnormal uptake as per Benamer et al.)[2]](/content/210/2016/31/3/img/IJNM-31-249-g002.png)
- (a) Normal dopamine transporter single-photon emission computed tomography scan appearance, normal dopamine transporter scan appearance with head of the caudate nucleus appearing like a full stop (large arrow), and the putamen appearing like tail (small arrow). (b) Abnormal dopamine transporter scan in our patient: The left side is normal with normal putaminal tail (large arrow). The right side has abnormal tracer uptake - absence of putaminal tail, but the normal appearance of the caudate nucleus was like a full stop (small open arrow) (Type 1 abnormal uptake as per Benamer et al.)[2]
DaT is the presynaptic transmembrane protein of the dopaminergic synapses. It transports dopamine back to the presynaptic neurons from the synaptic cleft. 123I-ioflupane is a molecular imaging agent used in DaT imaging to demonstrate the location and concentration of DaTs in the synapses. Tc99m-TRODAT and F-18 FDOPA positron emission tomography scan can also assess the DaT activity and the integrity of the presynaptic nigrostriatal function.[3]
DaT SPECT brain scan is helpful to distinguish between pre- (degenerative) and post-synaptic (such as drug-induced or vascular parkinsonism) parkinsonism.[4] DaT imaging is usually normal in postsynaptic parkinsonism, but abnormal in the presynaptic variety.[1] The degenerative presynaptic parkinsonism includes sub-types such as idiopathic Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Lewy body dementia, and corticobasal degeneration. Though this SPECT scan can distinguish between pre- and post-synaptic parkinsonism, it cannot distinguish among the sub-types of degenerative parkinsonism mentioned above.[14]
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2013;84:1288-95.
- [Google Scholar]
- Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group. Mov Disord. 2000;15:503-10.
- [Google Scholar]
- SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154-63.
- [Google Scholar]